Overview

Global Risk-based Monitoring Software Market is predicted to value over USD 600 million by 2027 end with a CAGR of over 13% during the forecast period 2020 to 2027.
 
Increasing efficiency and cost of risk-based monitoring solutions, growing investments by governments for bolstering clinical trials owing to its rising demand are some of the key factors driving the risk-based monitoring software market growth.

Risk-based Monitoring Software Market Segmentation:

By Type
• Enterprise
• Site

By Component
• Software
• Services

By Delivery Mode
• Licensed Enterprise
• Cloud-Based
• Web-Based

By End User
• CROs
• Medical Device Companies  
• Biopharmaceutical and Pharmaceutical Companies
• Others

By Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

The market is categorised into type, component, delivery mode, end user and region. The type segment is diversified into enterprise and site. The component segment is divided into software and services. The software segment is anticipated to hold the largest risk-based monitoring software market share, and this can be credited to the increasing demand for clinical trials and rising research and development expense in the life sciences sector. The delivery mode segment is divided into licensed enterprise, cloud-based and web-based.  The web-based segment is anticipated to lead the market owing to benefits provided such as improvements in productivity, cost-efficiency and time efficiency. The end user segment is fragmented into CROs, medical device companies, biopharmaceutical and pharmaceutical companies and others. The pharmaceutical and biopharmaceutical companies are predicted to dominate the market due to the availability of resources with these companies which lets them expand businesses in developed as well as developing economies.

Regional Analysis:
The North America region is expected to lead the market during the forecast period owing to increased funding from government bodies for clinical trials, non-stringent regulations and a presence of key market players. The Asia Pacific region is predicted to grow at a substantial rate owing to rising patient population, key market players expanding their businesses in the region, low operation costs.

Competitive Landscape:                            
Some of the key players are Oracle, Medidata Solutions, Parexel, Bioclinica, Bio-Optronics, IBM Corporation, DATATRAK, Veeva Systems, DSG, MasterControl, ERT, Forte Research Systems, MedNet Solutions, ArisGlobal, Anju Software, MaxisIT, Techsol Corporation, OpenClinica, CRF Health, Covance.      

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key market trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the global risk-based monitoring software market by type, by component, by delivery model, by end user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
• To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
      1.1 Objectives of the Study
      1.2 Market Definition
      1.3 Market Scope
            1.3.1 Years Considered for the Study
            1.3.2 Market Covered
       1.4 Currency
       1.5 Limitations
       1.6 Stakeholders
2. Research Methodology
       2.1 Research Data  
            2.1.1 Secondary Data
                    2.1.1.1 Key Data from Secondary Sources
            2.1.2 Primary Data
                     2.1.2.1 Key Data from Primary Sources
      2.2 Market Size Estimation
      2.3 Market Breakdown and Data Triangulation
      2.4 Assumptions for the Study  
3. Executive Summary
      3.1 Market Outlook
      3.2 Segment Outlook
      3.3 Competitive Insights
4. Market Variables, Trends & Scope
      4.1 Market Lineage Outlook
      4.2 Penetration and Growth Prospect Mapping
      4.3 Industry Value Chain Analysis
      4.4 Cost Analysis Breakdown
      4.5 Technology Overview
      4.6 Regulatory Framework on Country Level
            4.6.1 Reimbursement Framework    
            4.6.2 Standards and Compliances
5. Market Overview
      5.1 Market Dynamics
           5.1.1 Market Driver Analysis
           5.1.2 Market Restraint Analysis
           5.1.3 Industry Challenges
6. Market Analysis tools
      6.1 Industry Analysis - Porter’s
            6.1.1 Supplier Power
            6.1.2 Buyer Power
            6.1.3 Substitution Threat
            6.1.4 Threat from new entrants
            6.1.5 Competitive Rivalry
      6.2 Pestel Analysis
            6.2.1 Political Landscape
            6.2.2 Environmental Landscape
            6.2.3 Social landscape
            6.2.4 Technology landscape
            6.2.5 Legal Landscape
7. Risk-Based Monitoring Software Market, By Type Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
       7.1 Enterprise  
       7.2 Site       
8. Risk-Based Monitoring Software Market, By Component Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
       8.1 Software
       8.2 Services
9. Risk-Based Monitoring Software Market, By Delivery Mode Channel Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
         9.1 Licensed Enterprise
         9.2 Cloud-Based
         9.3 Web-Based
10. Risk-Based Monitoring Software Market, By End User Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
         10.1 CROs
         10.2 Medical Device Companies
         10.3 Biopharmaceutical and Pharmaceutical Companies
         10.4 Others
11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    11.1. Introduction
    11.2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019
             11.2.1. U.S.
             11.2.2. Canada
             11.2.3. Mexico
             11.2.4. Rest of North America
    11.3 Market Size (USD Mn) Forecast for North America 2020-2027
12. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    12.1. Introduction
    12.2. Regional Market Trends
    12.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019
            12.3.1. Brazil
            12.3.2. Venezuela
            12.3.3. Argentina
            12.3.4. Rest of Latin America
    12.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027
13. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    13.1. Introduction
    13.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019
            13.2.1. Germany
            13.2.2. U.K
            13.2.3. France
            13.2.4. Italy
            13.2.5 Switzerland
            13.2.6. Spain
            13.2.7. Russia
            13.2.8. Poland
            13.2.9. Rest of Western Europe
      13.3 Market Size (US$ Mn) Forecast for Europe 2020-2027
14. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
       14.1 Introduction
       14.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019
             14.2.1 Japan
             14.2.2 China
             14.2.3 Singapore
             14.2.4 Korea        
             14.2.5 India
             14.2.6 Australia and New Zealand
             14.2.7 ASEAN
             14.2.8 Rest of Asia Pacific
         14.3 Market Size (US$ Mn) Forecast for Asia Pacific 2020-2027
15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
          15.1 Introduction
          15.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019
                 15.2.1 UAE
                 15.2.2 South Africa
                 15.2.3 Egypt
                 15.2.4 Saudi Arabia
                 15.2.5 Rest of MEA
           15.3 Market Size (US$ Mn) Forecast for MEA 2020-2027
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
  16.1 Oracle
       16.1.1. Company Overview (HQ, Business Segments, Employee Strength)
       16.1.2. Product Portfolio
       16.1.3. SWOT Analysis
       16.1.4. Financial Overview
       16.1.5. Strategic Overview
 16.2 Medidata Solutions
      16.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      16.2.2. Product Portfolio
      16.2.3. SWOT Analysis
      16.2.4. Financial Overview
      16.2.5. Strategic Overview
 16.3 Parexel
      16.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      16.3.2. Product Portfolio
      16.3.3. SWOT Analysis
      16.3.4. Financial Overview
      16.3.5. Strategic Overview
  16.4 Bioclinica
      16.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      16.4.2. Product Portfolio
      16.4.3. SWOT Analysis
      16.4.4. Financial Overview
      16.4.5. Strategic Overview
  16.5 Bio-Optronics
      16.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      16.5.2. Product Portfolio
      16.5.3. SWOT Analysis
      16.5.4. Financial Overview
      16.5.5. Strategic Overview
  16.6 IBM Corporation
      16.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      16.6.2. Product Portfolio
      16.6.3. SWOT Analysis
      16.6.4. Financial Overview
      16.6.5. Strategic Overview
 16.7 DATATRAK
     16.7.1. Company Overview (HQ, Business Segments, Employee Strength)
     16.7.2. Product Portfolio
     16.7.3. SWOT Analysis
     16.7.4. Financial Overview
     16.7.5. Strategic Overview
 16.8 Veeva Systems
      16.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      16.8.2. Product Portfolio
      16.8.3. SWOT Analysis
      16.8.4. Financial Overview
      16.8.5. Strategic Overview
 16.9 DSG
      16.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      16.9.2. Product Portfolio
      16.9.3. SWOT Analysis
      16.9.4. Financial Overview
      16.9.5. Strategic Overview
 16.10 Forte Research Systems
      16.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      16.10.2. Product Portfolio
      16.10.3. SWOT Analysis
      16.10.4. Financial Overview
      16.10.5. Strategic Overview
 16.11 MedNet Solutions
      16.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      16.11.2. Product Portfolio
      16.11.3. SWOT Analysis
      16.11.4. Financial Overview
      16.11.5. Strategic Overview
 16.12 ArisGlobal
     16.12.1. Company Overview (HQ, Business Segments, Employee Strength)
     16.12.2. Product Portfolio
     16.12.3. SWOT Analysis
     16.12.4. Financial Overview
     16.12.5. Strategic Overview
 16.13 Anju Software
    16.13.1. Company Overview (HQ, Business Segments, Employee Strength)
    16.13.2. Product Portfolio
    16.13.3. SWOT Analysis
    16.13.4. Financial Overview
    16.13.5. Strategic Overview
 16.14 MaxisIT
    16.14.1. Company Overview (HQ, Business Segments, Employee Strength)
    16.14.2. Product Portfolio
    16.14.3. SWOT Analysis
    16.14.4. Financial Overview
    16.14.5. Strategic Overview
 16.15 Techsol Corporation
    16.15.1. Company Overview (HQ, Business Segments, Employee Strength)
    16.15.2. Product Portfolio
    16.15.3. SWOT Analysis
    16.15.4. Financial Overview
    16.15.5. Strategic Overview
17. Impact of COVID-19
    17.1. Positive influence on the healthcare industry
    17.2. The financial disruption of the manufacturing sector
    17.3. Impact of COVID-19 on emerging companies
    17.4. Significant mandates in the healthcare regulations initiated by administrations
    17.5. The overall economic slowdown of the developing and developed nations
18. Competitive Intelligence and Competitive Matrix
    18.1 Competitive Intelligence
    18.2 Competitive Matrix
19. Major Deals and Strategic Alliances Analysis
    19.1 Joint ventures
    19.2 Mergers and acquisitions              
    19.3 Licensing and partnerships
    19.4 Technology Collaborations
    19.5 Strategic Divestments
    19.6 Market Entry Strategies             
20. Relevant Case Studies and Latest News Updates
21. Key Market Takeaway Points from the Market Analysts at FutureWise Market Research

Tables

Figures